Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H21NO3 |
| Molecular Weight | 239.3107 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=CC=C1OCC(O)CNC(C)C
InChI
InChIKey=LFTFGCDECFPSQD-UHFFFAOYSA-N
InChI=1S/C13H21NO3/c1-10(2)14-8-11(15)9-17-13-7-5-4-6-12(13)16-3/h4-7,10-11,14-15H,8-9H2,1-3H3
Moprolol is a beta-adrenergic antagonist, or beta blocker, typically prescribed to treat hypertension, high blood pressure, angina pectoris, arrhythmias, anxiety, and glaucoma. Moprolol has been the subject for many clinical trials to study the effect moprolol has on both blood pressure and glaucoma. In clinical trials, Moprolol shows some effect on lowering blood pressure with no effects on the heart rate. Moprolol is currently off the market, most likely due to the manufacturer being in violation of US good manufacturing practices.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6120901
75 mg
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29576
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1839
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | |||
|
SUB09060MIG
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | |||
|
Moprolol
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | |||
|
CHEMBL156901
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | |||
|
DTXSID00863612
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | |||
|
4024
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | |||
|
100000080385
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | |||
|
227-254-7
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | |||
|
71213
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | |||
|
m1207
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | Merck Index | ||
|
5741-22-0
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | |||
|
C90797
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | |||
|
A94HCH4225
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY | |||
|
C009976
Created by
admin on Wed Apr 02 09:53:18 GMT 2025 , Edited by admin on Wed Apr 02 09:53:18 GMT 2025
|
PRIMARY |
ACTIVE MOIETY